Product-Page

user permission page

man jumping in sea

DURABILITY

High, durable skin clearance^1,2

UltIMMa-1 and UltIMMa-2

75% of SKYRIZI patients achieved PASI 90 at Week 16
>80% of SKYRIZI patients achieved PASI 90 at Week 52
At least twice the rate of response—achieving complete skin clearance at Week 52—with SKYRIZI vs ustekinumab in both studies:

—		SKYRIZI: ≥56%*
—		Ustekinumab: ≥21%

*P<0.0001 vs ustekinumab.

See the study designs

Go